Chi Zhang, Lauren Lu, Kristine Hanson, Ahmer Sultan, Patrick Starlinger, Rory Smoot, Michael L Kendrick, Mark Truty, Susanne G Warner, Cornelius Thiels
{"title":"Long-Term Reoperation Rates Following Pancreatoduodenectomy for Pancreatic Adenocarcinoma.","authors":"Chi Zhang, Lauren Lu, Kristine Hanson, Ahmer Sultan, Patrick Starlinger, Rory Smoot, Michael L Kendrick, Mark Truty, Susanne G Warner, Cornelius Thiels","doi":"10.1177/00031348241304021","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Short-term outcomes after pancreatoduodenectomy (PD) are well-studied, but long-term reoperation rates and their indications remain poorly characterized.</p><p><strong>Methods: </strong>A single-center retrospective chart review was performed on patients who underwent PD for pancreatic adenocarcinoma between 1/2011 and 12/2021. Reoperations occurring >90 days after PD were dichotomized to being related or unrelated to the index PD or pancreatic adenocarcinoma. The Kaplan-Meier analysis estimated the incidence of long-term reoperation at 1 and 5 years postoperatively.</p><p><strong>Results: </strong>Six-hundred twenty-eight patients were included. The 5-year incidence of any additional operation >90 days after PD was 30.0% (95% CI 23.2-36.2%), and the 5-year incidence of any long-term related reoperation was 21.2% (95% CI 15.0-26.8%). The most common indications for reoperations by 5-year incidence were cancer recurrence (12.8%, 95% CI 7.6-17.7%), incisional hernia (6.2%, 95% CI 2.6-9.7%), small bowel obstruction (1.3%, 95% CI 0.2-2.4%), and leak, fistula, or infection (1.0%, 95% CI 0.1-2.0%). Of the examined risk factors, only 90-day reoperation was found to be predictive of long-term related reoperations (<i>P</i> = 0.02). Additionally, the 5-year incidence of endoscopic or interventional radiology procedures was 20.2% (95% CI 14.5-25.4%). However, 40.9% (95% CI 33.6-47.3%) of patients required additional surgery or procedures of any kind between 90 days and 5 years after PD.</p><p><strong>Discussion: </strong>Within 5 years of PD, one in three patients required additional surgery, and one in five had operations for related indications. Related reoperative indications included recurrence, hernia, PD-specific complications, and small bowel obstruction. However, the rates of each of these reoperations were relatively low.</p>","PeriodicalId":7782,"journal":{"name":"American Surgeon","volume":" ","pages":"31348241304021"},"PeriodicalIF":1.0000,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Surgeon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00031348241304021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Short-term outcomes after pancreatoduodenectomy (PD) are well-studied, but long-term reoperation rates and their indications remain poorly characterized.
Methods: A single-center retrospective chart review was performed on patients who underwent PD for pancreatic adenocarcinoma between 1/2011 and 12/2021. Reoperations occurring >90 days after PD were dichotomized to being related or unrelated to the index PD or pancreatic adenocarcinoma. The Kaplan-Meier analysis estimated the incidence of long-term reoperation at 1 and 5 years postoperatively.
Results: Six-hundred twenty-eight patients were included. The 5-year incidence of any additional operation >90 days after PD was 30.0% (95% CI 23.2-36.2%), and the 5-year incidence of any long-term related reoperation was 21.2% (95% CI 15.0-26.8%). The most common indications for reoperations by 5-year incidence were cancer recurrence (12.8%, 95% CI 7.6-17.7%), incisional hernia (6.2%, 95% CI 2.6-9.7%), small bowel obstruction (1.3%, 95% CI 0.2-2.4%), and leak, fistula, or infection (1.0%, 95% CI 0.1-2.0%). Of the examined risk factors, only 90-day reoperation was found to be predictive of long-term related reoperations (P = 0.02). Additionally, the 5-year incidence of endoscopic or interventional radiology procedures was 20.2% (95% CI 14.5-25.4%). However, 40.9% (95% CI 33.6-47.3%) of patients required additional surgery or procedures of any kind between 90 days and 5 years after PD.
Discussion: Within 5 years of PD, one in three patients required additional surgery, and one in five had operations for related indications. Related reoperative indications included recurrence, hernia, PD-specific complications, and small bowel obstruction. However, the rates of each of these reoperations were relatively low.
背景:胰十二指肠切除术(PD)后的短期预后已得到充分研究,但长期再手术率及其适应症仍不清楚。方法:对2011年1月至2021年12月期间因胰腺腺癌接受PD治疗的患者进行单中心回顾性图表回顾。PD后60 ~ 90天发生的再手术分为与PD指数或胰腺腺癌相关或无关。Kaplan-Meier分析估计了术后1年和5年长期再手术的发生率。结果:纳入628例患者。PD后90天任何额外手术的5年发生率为30.0% (95% CI 23.2-36.2%),任何长期相关再手术的5年发生率为21.2% (95% CI 15.0-26.8%)。按5年发生率计算,再手术最常见的指征是癌症复发(12.8%,95% CI 7.6-17.7%)、切口疝(6.2%,95% CI 2.6-9.7%)、小肠梗阻(1.3%,95% CI 0.2-2.4%)、漏、瘘或感染(1.0%,95% CI 0.1-2.0%)。在检查的危险因素中,只有90天再手术可预测长期相关再手术(P = 0.02)。此外,5年内窥镜或介入放射检查的发生率为20.2% (95% CI 14.5-25.4%)。然而,40.9% (95% CI 33.6-47.3%)的患者在PD后90天至5年内需要额外的手术或任何类型的手术。讨论:在PD的5年内,三分之一的患者需要额外的手术,五分之一的患者因相关适应症进行了手术。相关的再手术指征包括复发、疝气、pd特异性并发症和小肠梗阻。然而,这些再手术的比率都相对较低。
期刊介绍:
The American Surgeon is a monthly peer-reviewed publication published by the Southeastern Surgical Congress. Its area of concentration is clinical general surgery, as defined by the content areas of the American Board of Surgery: alimentary tract (including bariatric surgery), abdomen and its contents, breast, skin and soft tissue, endocrine system, solid organ transplantation, pediatric surgery, surgical critical care, surgical oncology (including head and neck surgery), trauma and emergency surgery, and vascular surgery.